Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pegah Seif, Ph.D.

Concepts (12)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Pegah Seif's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Pegah Seif has written about over time.
Affect, 1 publications between 2021 and 2021, average publication date January 2021. Antipsychotic Agents, 1 publications between 2022 and 2022, average publication date March 2022. Double-Blind Method, 1 publications between 2022 and 2022, average publication date March 2022. Iran, 1 publications between 2022 and 2022, average publication date March 2022. Male, 1 publications between 2022 and 2022, average publication date March 2022. Schizophrenia, 1 publications between 2022 and 2022, average publication date March 2022. Treatment Outcome, 1 publications between 2022 and 2022, average publication date March 2022. Humans, 3 publications between 2021 and 2024, average publication date June 2022. Bipolar Disorder, 2 publications between 2021 and 2024, average publication date August 2022. Cross-Sectional Studies, 1 publications between 2024 and 2024, average publication date March 2024. Diagnosis, Dual (Psychiatry), 1 publications between 2024 and 2024, average publication date March 2024. Substance-Related Disorders, 1 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Seif's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.